BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 32577507)

  • 1. The clonal evolution of metastatic colorectal cancer.
    Dang HX; Krasnick BA; White BS; Grossman JG; Strand MS; Zhang J; Cabanski CR; Miller CA; Fulton RS; Goedegebuure SP; Fronick CC; Griffith M; Larson DE; Goetz BD; Walker JR; Hawkins WG; Strasberg SM; Linehan DC; Lim KH; Lockhart AC; Mardis ER; Wilson RK; Ley TJ; Maher CA; Fields RC
    Sci Adv; 2020 Jun; 6(24):eaay9691. PubMed ID: 32577507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiregion whole-exome sequencing of matched primary and metastatic tumors revealed genomic heterogeneity and suggested polyclonal seeding in colorectal cancer metastasis.
    Wei Q; Ye Z; Zhong X; Li L; Wang C; Myers RE; Palazzo JP; Fortuna D; Yan A; Waldman SA; Chen X; Posey JA; Basu-Mallick A; Jiang BH; Hou L; Shu J; Sun Y; Xing J; Li B; Yang H
    Ann Oncol; 2017 Sep; 28(9):2135-2141. PubMed ID: 28911083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spatial and temporal clonal evolution of intrahepatic cholangiocarcinoma.
    Dong LQ; Shi Y; Ma LJ; Yang LX; Wang XY; Zhang S; Wang ZC; Duan M; Zhang Z; Liu LZ; Zheng BH; Ding ZB; Ke AW; Gao DM; Yuan K; Zhou J; Fan J; Xi R; Gao Q
    J Hepatol; 2018 Jul; 69(1):89-98. PubMed ID: 29551704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clonal Evolution and Timing of Metastatic Colorectal Cancer.
    Siraj S; Masoodi T; Siraj AK; Azam S; Qadri Z; Ahmed SO; AlBalawy WN; Al-Obaisi KA; Parvathareddy SK; AlManea HM; AlHussaini HF; Abduljabbar A; Alhomoud S; Al-Dayel FH; Alkuraya FS; Al-Kuraya KS
    Cancers (Basel); 2020 Oct; 12(10):. PubMed ID: 33053768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unstable Genome and Transcriptome Dynamics during Tumor Metastasis Contribute to Therapeutic Heterogeneity in Colorectal Cancers.
    Cho SY; Chae J; Na D; Kang W; Lee A; Min S; Kang J; Choi B; Lee J; Sung CO; Chuang JH; Lee C; Lee WS; Park H; Kim JI
    Clin Cancer Res; 2019 May; 25(9):2821-2834. PubMed ID: 30670495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic heterogeneity and clonal evolution during metastasis in breast cancer patient-derived tumor xenograft models.
    Sprouffske K; Kerr G; Li C; Prahallad A; Rebmann R; Waehle V; Naumann U; Bitter H; Jensen MR; Hofmann F; Brachmann SM; Ferretti S; Kauffmann A
    Comput Struct Biotechnol J; 2020; 18():323-331. PubMed ID: 32099592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multi-cancer analysis of clonality and the timing of systemic spread in paired primary tumors and metastases.
    Hu Z; Li Z; Ma Z; Curtis C
    Nat Genet; 2020 Jul; 52(7):701-708. PubMed ID: 32424352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rare subclonal sequencing of breast cancers indicates putative metastatic driver mutations are predominately acquired after dissemination.
    Lawrence-Paul MR; Pan TC; Pant DK; Shih NNC; Chen Y; Belka GK; Feldman M; DeMichele A; Chodosh LA
    Genome Med; 2024 Feb; 16(1):26. PubMed ID: 38321573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymph Node Metastases in Colon Cancer Are Polyclonal.
    Ulintz PJ; Greenson JK; Wu R; Fearon ER; Hardiman KM
    Clin Cancer Res; 2018 May; 24(9):2214-2224. PubMed ID: 29203589
    [No Abstract]   [Full Text] [Related]  

  • 10. Patient-derived xenografts undergo mouse-specific tumor evolution.
    Ben-David U; Ha G; Tseng YY; Greenwald NF; Oh C; Shih J; McFarland JM; Wong B; Boehm JS; Beroukhim R; Golub TR
    Nat Genet; 2017 Nov; 49(11):1567-1575. PubMed ID: 28991255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multi-modal data resource for investigating topographic heterogeneity in patient-derived xenograft tumors.
    Rajaram S; Roth MA; Malato J; VandenBerg S; Hann B; Atreya CE; Altschuler SJ; Wu LF
    Sci Data; 2019 Oct; 6(1):253. PubMed ID: 31672976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic Heterogeneity in Therapy-Naïve Synchronous Primary Breast Cancers and Their Metastases.
    Ng CKY; Bidard FC; Piscuoglio S; Geyer FC; Lim RS; de Bruijn I; Shen R; Pareja F; Berman SH; Wang L; Pierga JY; Vincent-Salomon A; Viale A; Norton L; Sigal B; Weigelt B; Cottu P; Reis-Filho JS
    Clin Cancer Res; 2017 Aug; 23(15):4402-4415. PubMed ID: 28351929
    [No Abstract]   [Full Text] [Related]  

  • 13. Patient-derived xenografts of central nervous system metastasis reveal expansion of aggressive minor clones.
    Tew BY; Legendre C; Schroeder MA; Triche T; Gooden GC; Huang Y; Butry L; Ma DJ; Johnson K; Martinez RA; Pierobon M; Petricoin EF; O'shaughnessy J; Osborne C; Tapia C; Buckley DN; Glen J; Bernstein M; Sarkaria JN; Toms SA; Salhia B
    Neuro Oncol; 2020 Jan; 22(1):70-83. PubMed ID: 31433055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Challenges in Stratifying the Molecular Variability of Patient-Derived Colon Tumor Xenografts.
    Cybulska M; Olesinski T; Goryca K; Paczkowska K; Statkiewicz M; Kopczynski M; Grochowska A; Unrug-Bielawska K; Tyl-Bielicka A; Gajewska M; Mroz A; Dabrowska M; Karczmarski J; Paziewska A; Zając L; Bednarczyk M; Mikula M; Ostrowski J
    Biomed Res Int; 2018; 2018():2954208. PubMed ID: 30662905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clonal heterogeneity of colon cancer with liver metastases.
    Chen G; Zhu W; Liu Y; Zhang L; Xie L; Song X; Song X
    J Gastroenterol; 2023 Jul; 58(7):642-655. PubMed ID: 37042990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spatio-Temporal Genomic Heterogeneity, Phylogeny, and Metastatic Evolution in Salivary Adenoid Cystic Carcinoma.
    Liu B; Mitani Y; Rao X; Zafereo M; Zhang J; Zhang J; Futreal PA; Lozano G; El-Naggar AK
    J Natl Cancer Inst; 2017 Oct; 109(10):. PubMed ID: 29117356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The genomic landscape of metastasis in treatment-naïve breast cancer models.
    Ross C; Szczepanek K; Lee M; Yang H; Qiu T; Sanford JD; Hunter K
    PLoS Genet; 2020 May; 16(5):e1008743. PubMed ID: 32463822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deciphering clonal dynamics and metastatic routines in a rare patient of synchronous triple-primary tumors and multiple metastases with MPTevol.
    Chen Q; Wu QN; Rong YM; Wang S; Zuo Z; Bai L; Zhang B; Yuan S; Zhao Q
    Brief Bioinform; 2022 Sep; 23(5):. PubMed ID: 35598328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spatial and temporal clonal evolution during development of metastatic urothelial carcinoma.
    Thomsen MB; Nordentoft I; Lamy P; Høyer S; Vang S; Hedegaard J; Borre M; Jensen JB; Ørntoft TF; Dyrskjøt L
    Mol Oncol; 2016 Nov; 10(9):1450-1460. PubMed ID: 27582092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subclonal Genomic Architectures of Primary and Metastatic Colorectal Cancer Based on Intratumoral Genetic Heterogeneity.
    Kim TM; Jung SH; An CH; Lee SH; Baek IP; Kim MS; Park SW; Rhee JK; Lee SH; Chung YJ
    Clin Cancer Res; 2015 Oct; 21(19):4461-72. PubMed ID: 25979483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.